Evidence map›Paper›PMID 25319469›Full record

ArticleJournal of endocrinological investigation2015

Effect of a single injection of testosterone enanthate on 17β estradiol and bone turnover markers in hypogonadal male patients.

V Camozzi, G Bonanni, A Frigo, M Piccolo, S Ferasin, M Zaninotto, M Boscaro, G Luisetto

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

V CamozziDepartment of Medicine, Unit of Endocrinology, University of Padova, via Ospedale 105, 35128, Padua, Italy. valentina.camozzi@unipd.it.
G BonanniDepartment of Medicine, Unit of Endocrinology, University of Padova, via Ospedale 105, 35128, Padua, Italy. guglielmo.bonanni@unipd.it.
A FrigoDepartment of Cardiac, Thoracic and Vascular Sciences, Unit of Biostatistics, Epidemiology and Public Health, University of Padova, via Loredan 18, 35131, Padua, Italy. annachiara.frigo@unipd.it.
M PiccoloDepartment of Medicine, Unit of Endocrinology, University of Padova, via Ospedale 105, 35128, Padua, Italy. michele.piccolo@unipd.it.
S FerasinDepartment of Medicine, Unit of Endocrinology, University of Padova, via Ospedale 105, 35128, Padua, Italy. sergio.ferasin@unipd.it.
M ZaninottoDepartment of Medical Laboratory, University of Padova, via Giustiniani 2, 35128, Padua, Italy. martina.zaninotto@sanita.padova.it.
M BoscaroDepartment of Medicine, Unit of Endocrinology, University of Padova, via Ospedale 105, 35128, Padua, Italy. marco.boscaro@unipd.it.
G LuisettoDepartment of Medicine, Unit of Endocrinology, University of Padova, via Ospedale 105, 35128, Padua, Italy. giovanni.luisetto@unipd.it.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSeveral clinical studies testify the critical role played by estrogens in male bone metabolism. The aim of our study is to assess the effect of a single injection of testosterone enanthate in a group of hypogonadal men on 17β estradiol serum levels and some bone metabolic parameters.

methodTwenty-one hypogonadal males were given one testosterone enanthate injection (250 mg). Blood samples were drawn before the injection and after 1, 2 and 3 weeks. The following variables were measured: Total testosterone (TT), 17β estradiol (17β E2), Sex hormone binding globulin, total alkaline phosphatase, osteocalcin, and C-telopeptide of type I collagen (CTx).

resultsAfter testosterone injection, both TT and 17β E2 increased, peaking 1 week after the injection. Individual observation of the response of 17β E2 to testosterone showed that a subgroup (n = 9) failed to respond with any increase in 17β E2 at any of the weekly tests (group E2-), while the remainder (n = 12) showed a significant increase in 17β E2, which reached a mean value three times higher than at baseline (group E2+). The E2- patients reached a TT peak lower than that observed in the E+ group. CTx serum levels declined progressively in the E2+ group, reaching the significance (p = 0.03) at the end of the study, while it did not change in E- group.

conclusionThis study suggests that a single injection of testosterone might have different effects on the production of endogenous estrogens, and a significant reduction of bone resorption parameters takes place only in the patients who show a significant increase of 17ß estradiol in response to testosterone administration.

Indexed as

AdultAndrogensBiomarkersBone RemodelingEstradiolHumansHypogonadismMaleMiddle AgedTestosteroneAndrogensBiomarkersEstradiolTestosteronetestosterone enanthateBone metabolismBone turnover markersEstrogensHypogonadismTestosterone

Identifiers

PMID25319469
OpenAlexW1982475070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.